Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1995 2
1996 5
1997 4
1998 3
1999 3
2000 3
2001 3
2002 4
2003 2
2004 6
2005 8
2006 4
2007 11
2008 17
2009 9
2010 5
2011 3
2012 3
2013 15
2014 17
2015 21
2016 24
2017 18
2018 22
2019 19
2020 28
2021 46
2022 48
2023 33
2024 28
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Expert consensus on vitamin D in osteoporosis.
Lei S, Zhang X, Song L, Wen J, Zhang Z, Tian J, Yang R, Xu S, Qiu S, MacIsaac RJ, Aleksova J, Mac-Way F, Dupuis MÈ, Benaiges D, Mauricio D, Sommer AP, Barzilay JI, Gallagher JC, Pan L, Ji L, Fang P, Li Y, Liu Q, Zhao J, Xue Y, Shen Y, Wang L, Han J, Liu G. Lei S, et al. Among authors: mauricio d. Ann Jt. 2025 Jan 21;10:1. doi: 10.21037/aoj-24-48. eCollection 2025. Ann Jt. 2025. PMID: 39981430 Free PMC article. Review.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Battelino T, et al. Among authors: mauricio d. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6. Lancet Diabetes Endocrinol. 2023. PMID: 36493795 Review.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
The People-First Liver Charter.
Lazarus JV, Ivancovsky Wajcman D, Pannain S, Brennan PN, Manolas MI, Jepsen P, Treloar C, Arora AK, Matthews PC, Picchio CA, White TM, Grebely J, Vaz J, Hagström H, Rabin KH, Isaacs S, Ribeiro RT, Roden M, Betel M, Willemse J, Díaz LA, Allen AM, Alkhouri N, Schattenberg JM, Mauricio D, Rinella ME, Pose E, Tsochatzis EA, Ninburg M, Cusi K, Alazawi W, Duseja A, Frühbeck G, Lofton H, Jaisinghani P, Kanwal F, Shiha G, Zelber-Sagi S, Holden L, Villota-Rivas M. Lazarus JV, et al. Among authors: mauricio d. Nat Med. 2025 Jul;31(7):2109-2116. doi: 10.1038/s41591-025-03759-8. Nat Med. 2025. PMID: 40473951 No abstract available.
Perioperative glycaemic control for people with diabetes undergoing surgery.
Bellon F, Solà I, Gimenez-Perez G, Hernández M, Metzendorf MI, Rubinat E, Mauricio D. Bellon F, et al. Among authors: mauricio d. Cochrane Database Syst Rev. 2023 Aug 1;8(8):CD007315. doi: 10.1002/14651858.CD007315.pub3. Cochrane Database Syst Rev. 2023. PMID: 37526194 Free PMC article. Review.
395 results